Invitation

Routebeschrijving:
Komende van Breda – Antwerpen
Volg de E19 richting Brussel tot aan de Brusselse Ring (R0). Neem niet de afrit
Vilvoorde vóór de Ring. Ga de Brusselse Ring op richting Gent en neem na het
viaduct afrit 6, Militair Hospitaal. Beneden aan de afrit volgt u de pijlen naar links
richting Living Tomorrow. U vindt ons op ongeveer 200 m van de afrit.
Komende van Gent – Charleroi
Neem de Brusselse Ring (R0) richting Zaventem. Neem voor het viaduct afrit 6,
Militair Hospitaal. Beneden aan de afrit gaat u rechts en meteen weer rechts de
Indringingsweg op. U vindt Living Tomorrow op ongeveer 200 m aan de
rechterzijde.
Itinéraire:
En venant de Breda – Anvers
Suivez la E19 direction Bruxelles jusqu’au Ring de Bruxelles (R0). Ne prenez pas
la sortie Vilvorde avant le Ring. Prenez le Ring de Bruxelles, en direction de Gand
et empruntez ensuite, après le viaduc, la sortie 6, Hôpital Militaire. Au bas de la
sortie, suivez les flèches de gauche en direction de Living Tomorrow. Nous nous
trouvons à environ 200 m de la sortie.
En venant de Gand – Charleroi
Prenez le Ring de Bruxelles (R0) en direction de Zaventem. Prenez avant le
viaduc la sortie 6, Hôpital Militaire. En bas de la sortie, prenez à droite, puis tout de
suite après encore à droite en empruntant le Indringingsweg. Vous trouverez
Living Tomorrow à environ 200 m sur la droite.
Invitation
BREAST CANCER AND LYMPH
NODES : STATE OF THE ART.
Organizing : F.Buxant – JC.Schobbens
Chairs : M.Van Goethem – P.Cusumano
Pre-registration required!
www.seno.be
Saturday
12 January 2013
Living Tomorrow - Indringingsweg 1 - 1800 Vilvoorde – T 02 263 01 33
www.livingtomorrow.com - [email protected]
HU
UH
HU
U
09:00-13:00
Living Tomorrow
Indringingsweg 1
1800 Vilvoorde
Pre‐registration required ! Non‐members Fee : 80€ Secretariat : [email protected] – 016/34.37.70 HU
UH
Program
Dear Colleague,
Over the last decades, the increasing proportion breast
cancers (BC) are small at diagnosis parallels less aggressive
BC surgery. This also involves axillary staging in early breast
cancer using the sentinel lymph node biopsy (SLNB), now
standard of care. This clearly reduced the frequency we have
to deal with the very important invalidating complications
following a complete axillary dissection : “lymphedema, arm
and shoulder dysfunction”. Improve quality of life further,
early day indications of SLNB limited to a never operated
breast with a unifocal cT1N0 lesion have turned to a
procedure with almost no contra-indications: pregnancy, neoadjuvant chemotherapy, cT2-T3N0, multifocal or even
multicentric lesions are all allowed. The SBS/BVS believes it
is now time to discuss these new indications but also today’s
greatest controversy namely the one of how to select patients
with a positive SLN for further axillary dissection, the way and
extend SLNs should be assessed by our radiologists
(ultrasound) and pathologists (peroperative vs postoperative,
cytokeratins vs H&E, number of dissection levels, etc) and
the meaning of an ‘involved’ SLN for adjuvant systemic and
local, read radiotherapy. The recently emerged information
that lymphedema prevention by intensive physiotherapy is of
little use will also be debated. As usual, this SBS/BVS
symposium will find an answer to most of your remaining
questions and will probably change your daily clinical
practice! Meet you there!
08:30-09:00 Welcome coffee
09:00-09:30 Imaging of the axilla
C.Van Ongeval - KULeuven
09:30-10:00 Is there still a place for axillary dissection in 2013?
JC.Schobbens - Genk
10:00-10:30 Lymphoedema : mechanism, prevention and
treatment
N.Devoogdt - KULeuven
10:30-11:00 Coffee break and SBS – BVS Elections
11:00-11:30 Point of view of the oncologist
F.Duhoux - UCL
11:30-12:00 Point of view of the
radiotherapist
P.Coucke – CHU Liège
Drs F.Buxant (Brussels) & JC.Schobbens (Genk)
12:00-12:30 Situation in Belgium : overview of
different breast clinics
F.Buxant - Ixelles
12:30-13:00 Round table & Discussion
13:00
Reception with refreshments